Inhibition_NN
of_IN
vitamin_NN
D_NN
receptor-retinoid_JJ
X_NN
receptor-vitamin_JJ
D_NN
response_NN
element_NN
complex_NN
formation_NN
by_IN
nuclear_JJ
extracts_NNS
of_IN
vitamin_NN
D-resistant_JJ
New_JJ
World_NN
primate_JJ
cells_NNS
._.

Most_JJS
New_JJ
World_NN
primate_NN
-LRB-_-LRB-
NWP_NN
-RRB-_-RRB-
genera_NN
evolved_VBD
to_TO
require_VB
high_JJ
circulating_VBG
levels_NNS
of_IN
steroid_NN
hormones_NNS
and_CC
vitamin_NN
D_NN
._.

We_PRP
hypothesized_VBD
that_IN
an_DT
intracellular_JJ
vitamin_NN
D_NN
binding_NN
protein_NN
-LRB-_-LRB-
IDBP_NN
-RRB-_-RRB-
,_,
present_JJ
in_IN
both_CC
nuclear_JJ
and_CC
cytoplasmic_JJ
fractions_NNS
of_IN
NWP_NN
cells_NNS
,_,
or_CC
another_DT
protein_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
may_MD
cause_VB
or_CC
contribute_VB
to_TO
the_DT
steroid_NN
hormone-resistant_JJ
state_NN
in_IN
NWP_NN
by_IN
disruption_NN
of_IN
the_DT
receptor_NN
dimerization_NN
process_NN
and\/or_CC
by_IN
interference_NN
of_IN
receptor_NN
complex_NN
binding_NN
to_TO
the_DT
consensus_NN
response_NN
elements_NNS
present_JJ
in_IN
the_DT
enhancer_NN
regions_NNS
of_IN
steroid-responsive_JJ
genes_NNS
._.

We_PRP
employed_VBD
electromobility_NN
shift_NN
assay_NN
-LRB-_-LRB-
EMSA_NN
-RRB-_-RRB-
to_TO
screen_VB
for_IN
the_DT
presence_NN
of_IN
proteins_NNS
capable_JJ
of_IN
binding_NN
to_TO
the_DT
vitamin_NN
D_NN
response_NN
element_NN
-LRB-_-LRB-
VDRE_NN
-RRB-_-RRB-
._.

Nuclear_JJ
and_CC
post-nuclear_JJ
extracts_NNS
were_VBD
prepared_VBN
from_IN
two_CD
B-lymphoblastoid_JJ
cell_NN
lines_NNS
known_VBN
to_TO
be_VB
representative_JJ
of_IN
the_DT
vitamin_NN
D-resistant_JJ
and_CC
wild_JJ
type_NN
phenotypes_NNS
,_,
respectively_RB
._.

The_DT
extracts_NNS
were_VBD
compared_VBN
for_IN
their_PRP$
ability_NN
to_TO
retard_VB
the_DT
migration_NN
of_IN
radiolabeled_VBN
double_JJ
stranded_JJ
oligomers_NNS
representative_JJ
of_IN
the_DT
VDREs_NNS
of_IN
the_DT
human_JJ
osteocalcin_NN
and_CC
the_DT
mouse_NN
osteopontin_NN
gene_NN
promoters_NNS
._.

A_DT
specific_JJ
,_,
retarded_JJ
band_NN
containing_VBG
VDR-RXR_NN
was_VBD
identified_VBN
when_WRB
wild_JJ
type_NN
cell_NN
but_CC
not_RB
when_WRB
vitamin_NN
D-resistant_JJ
cell_NN
nuclear_JJ
extract_NN
was_VBD
used_VBN
in_IN
the_DT
binding_VBG
reaction_NN
with_IN
either_DT
probe_NN
._.

In_IN
addition_NN
,_,
vitamin_NN
D-resistant_JJ
cell_NN
nuclear_JJ
extract_NN
contained_VBD
a_DT
protein_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
which_WDT
was_VBD
bound_VBN
specifically_RB
to_TO
the_DT
VDRE_NN
and_CC
was_VBD
capable_JJ
of_IN
completely_RB
inhibiting_VBG
VDR-RXR-VDRE_JJ
complex_NN
formation_NN
;_:
these_DT
effects_NNS
were_VBD
not_RB
demonstrated_VBN
with_IN
nuclear_JJ
extract_NN
from_IN
the_DT
wild_JJ
type_NN
cell_NN
line_NN
or_CC
with_IN
the_DT
post-nuclear_JJ
extract_NN
of_IN
the_DT
vitamin_NN
D-resistant_JJ
cell_NN
line_NN
._.

We_PRP
conclude_VBP
that_IN
a_DT
VDRE-binding_JJ
protein_NN
-LRB-_-LRB-
s_NNS
-RRB-_-RRB-
,_,
distinct_JJ
from_IN
IDBP_NN
and_CC
present_JJ
in_IN
nuclear_JJ
extract_NN
of_IN
cells_NNS
from_IN
a_DT
prototypical_JJ
vitamin_NN
D-resistant_JJ
NWP_NN
,_,
is_VBZ
capable_JJ
of_IN
inhibiting_VBG
normal_JJ
VDR-RXR_NN
heterodimer_NN
binding_NN
to_TO
the_DT
VDRE_NN
._.

